Online
| Post a Message | Explore Forums | Browse Stock Messages | Hot Discussions | Top rated Messages | Top Boarders | |
|
|
|
Sun Pharmaceutical Industries
buy sunpharma
Posted by :
GuestTracked by: 0 Boarder
target 1530-1552 do not sell ...
most overvalued
Posted by : psgsTracked by: 0 Boarder
this stock is looking extremely overvalued at its 52 week high today's price. simply book profits and exit the counter. not worth in buying at this rate. if you hold the stock already exit in this rally. switch to better stocks like Biocon or Monsanto which will do better in the times ahead.
swamy.
...
NSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceuticals Industries Ltd has informed the Exchange regarding the press release dated August 14, 2008, titled "Sun Pharma Announces U.S. FTC Clearance for Taro Tender Offer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated August 14, 2008 titled "Sun Pharma Announces U.S. FTC Clearance for Taro Tender Offer"
Press Release:
"Sun Pharmaceutical Industries Ltd on August 14, 2008 announced that on August 13, 2008, the U.S. Federal Trade Commission (FTC) granted early termination of the antitrust waiting period under the Hart-Scott-Rodino Act (HSR) for the previously announced Tender Offer by Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), a subsidiary of Sun Pharma, for all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro). Clearance under HSR meets one of the conditions to the Tender Offer. The Offer is scheduled to expire at 5:00 p.m., New York City time, on Tuesday, September 02, 2008 unless extended.
The Offer was commenced on June 30, 2008 in order to comply with the terms of the Option Agreement between Alkaloida and the controlling shareholders of Taro. The complete terms and conditions are set out in the Offer to Purchase, which is filed with the U.S. Securities and Exchange Commission. Taro shareholders may obtain copies of all of the offering documents, including the Offer to Purchase, free of charge at the SECs website
(www.sec.gov) or by directing a request to MacKenzie Partners, Inc., the Information Agent for the offer, at 105 Madison Avenue, New York, New York 10016, (212) 929-5500 (Call Collect) or Call Toll-Free (800) 322-2885,
Email: tenderoffer@mackenziepartners.com.
Greenhill & Co., LLC is acting as the Dealer Manager for the Tender Offer and MacKenzie is acting as the Information Agent for the Tender Offer."...
buy sunpharm
Posted by : GuestTracked by: 1 Boarder
by 28/08 price will be between 1550 -1600 level, buy or hold, do not sell...
A GR8 Buy.
Posted by : TRUETALKTracked by: 0 Boarder
Sun Pharma is agreat buy. Truetalk....
NSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceuticals Industries Ltd has informed the Exchange vides it letter dated July 29, 2008 regarding the press release dated July 28, 2008, titled "Sun Pharma reaffirms commitment to Taro Facilities and employees". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated July 30, 2008 titled "Sun Pharma gets USFDA approval for generic Depakote delayed release tablets"...
NSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceuticals Industries Ltd has informed the Exchange regarding a press release dated July 30 2008, titled "Sun Pharma gets USFDA approval for generic Depakote (R) delayed release tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
BSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release titled "Sun Pharma reaffirms commitment to Taro facilities and employees"...
NSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceuticals Industries Ltd has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 06, 2008....
Sun Pharma Q1 net profit up at Rs 501 cr
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharma has announced its first quarter results. The company's Q1 net profit was up at Rs 501 crore versus Rs 227.2 crore....
NSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceuticals Industries Ltd has informed the Exchange regarding a press release dated July 28, 2008, titled "A quarter of all-round strong growth, Sales up 66%, Profit up 121%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
taro pharma
Posted by : GuestTracked by: 0 Boarder
sell sun pharma may go below 1315 taro pending and time taking...
NSE Announcements on Sun Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Sun Pharmaceuticals Industries Ltd has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 67081 lacs for quarter ending on 30-JUN-2008 against Rs. 50881 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 28078 lacs for the quarter ending on 30-JUN-2008 against Rs. 22539 lacs for the quarter ending on 30-JUN-2007....
More from the Pharmaceuticals Sector
see more
Boarders tracking Sun Pharma
News Updates on Sun Pharma
